Abstract:Cardiovascular diseases (CVD) are the leading cause of death worldwide, and smoking remains the most significant preventable risk factor. The contribution of nicotine, the addictive component of all tobacco products, to smoking-related CVD remains poorly understood. In addition to smoking, obesity is also a major risk factor for the development of CVD. Recent studies indicate that individuals who are overweight or obese are at greater risk of nicotine product usage. With more than 40% of the US population affected by obesity, the combined effects of obesity and nicotine on cardiovascular (CV) health warrant urgent investigation. In the present study we investigated the combined effects of nicotine exposure and a high fat diet (HFD) on CV function.Male C57BL/6N mice (8 wk-old) were placed on either a HFD (60 kcal% Fat) or standard chow (SC, 22 kcal% Fat) and exposed to room air (RA) or nicotine vapor (NIC, 12 hr/day during the active phase) for 10 weeks (n=10-15/group). Mice with HFD exposure alone exhibited significantly greater weight gain at 10 weeks vs. SC-RA controls (122.5±9.8% increase in body weight in HFD-RA vs. 40.7±3.3% in SC-RA, p < 0.0001), whereas concurrent nicotine inhalation significantly reduced this weight gain (66.5±5.8% in HFD-NIC group, p < 0.0001). In the HFD-NIC group, blood pressure (BP) monitoring via telemetry (24 hours) revealed non-significant increases in BP in the inactive phase, coupled with a significant (p < 0.05) reduction in the expected dipping in BP during the inactive compared to the active phase (HFD-NIC: 4.5±1.2; SC-RA: 11.3±2.2; HFD-RA: 12.4±1.0 and SC-NIC: 9.7±4.6 mmHg). LV catheterization showed that mice exposed to both nicotine and HFD had elevated LV end diastolic pressure (HFD-NIC: 14.1±0.7; SC-RA: 4.5±0.8; HFD-RA: 2.8±0.7 and SC-NIC: 3.9±1.3 mmHg; p<0.05) and prolonged time constant of LV relaxation (Tau). LV RNAseq analysis revealed that HFD-NIC resulted in 70 differentially expressed genes (36 upregulated and 34 downregulated) unique from nicotine or HFD alone, with multiple differentially regulated pathways including dilated cardiomyopathy signaling pathway (p = 2.8E-04). Plasma NT-pro-BNP levels were significantly increased in HFD-RA mice vs. SC-RA controls, whereas this response was absent in HFD-NIC. Finally, HFD+NIC led to greater impairment of endothelium-dependent vasorelaxation in thoracic aortas compared to either treatment alone.In conclusion, although nicotine reduced HFD-induced weight gain, combined exposure to inhaled nicotine and HFD led to greater cardiovascular dysfunction including dysregulation in physiological blood pressure responses, LV diastolic dysfunction, and greater impairment of endothelial-dependent vascular function. National Institute of Health [grant numbers HL135635 (to JDG, EL and XY); HL146098, HL146514, and HL151398 (to DJL.); and F30HL160071 (to AKW)]; Department of Veterans Affairs (BX004294 to EL) and the American Heart Association [Award 829761 (to AKW) and Award 20POST35200075 (to ZL)]. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Abstract 276: Nicotine Infusion Fails to Induce Abdominal Aortic Aneurysmsin LDL Receptor Deficient Mice

Nicotine induces vasa vasorum stenosis in the aortic wall

Nicotine induces proinflammatory responses in macrophages and the aorta leading to acceleration of atherosclerosis in low-density lipoprotein receptor(-/-) mice

Abstract 278: Protective Effects of Niacin in a Murine Model of Abdominal Aortic Aneurysms

Mast Cell Plays Pivotal Role in Nicotine-Induced Atherosclerotic Plaque Progress and Instability

Abstract 525: Angiotensin Ii Type 1a Receptor Deletion In Vascular Smooth Muscle Cells Prevent Abdominal Aortic Aneurysm Formation Induced By Angiotensin Ii Plus β-aminopropionitrile

Angiotensin II constricts mouse iliac arteries: possible mechanism for aortic aneurysms

Nicotine exacerbates atherosclerosis and plaque instability via NLRP3 inflammasome activation in vascular smooth muscle cells

Doxycycline Does Not Influence Established Abdominal Aortic Aneurysms in Angiotensin II-Infused Mice

Apob-Containing Lipoproteins Contribute To Augmentation Of Angii-Induced Abdominal Aortic Aneurysms

Smooth Muscle Cellspecific Deficiency Of Ace Attenuates Angi-Induced Ascending Aortic Dilation In Male Ldl Receptor -/- Mice

Abstract 1005: Hypertriglyceridemia Promotes Aortic Aneurysm Formation And Rupture In Angiotensin Ii Infused Mice

Nicotine Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice by Activating Α7 Nicotinic Acetylcholine Receptor on Mast Cells

One Amino Acid Change of Angiotensin II Diminishes Its Effects on Abdominal Aortic Aneurysm

Metabolomic Profiling of Angiotensin-II-Induced Abdominal Aortic Aneurysm in Ldlr-/- Mice Points to Alteration of Nitric Oxide, Lipid, and Energy Metabolisms

Abstract 12379: AT1-AA (Angiotensin II Type 1 Receptor Autoantibody) Aggravates Abdominal Aortic Aneurysm Through Activating AT1R/Gq Allosterically

Cardiovascular dysfunction induced by combined exposure to nicotine inhalation and high fat diet

Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice

Artesunate Attenuated the Progression of Abdominal Aortic Aneurysm in a Mouse Model

Indoleamine 2 3-dioxygenase knockout limits angiotensin II-induced aneurysm in low density lipoprotein receptor-deficient mice fed with high fat diet

Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis